Please sign in to follow a disease.
Twin study aims to unlock secrets of metabolic syndrome and liver disease
NCT ID NCT07181018
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 1,500 twins aged 15-44 in Poland over 5 years to learn how metabolic syndrome and related liver problems develop. Researchers will look at genetics, environment, and gut bacteria. Some twins will get an educational program to encourage healthy changes, while their co-twin serves as a control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- educational intervention
- What this could lead to
- If successful, this could reveal key risk factors and genetic influences for metabolic syndrome and liver disease, pointing toward better prevention strategies.
- What could go wrong
- This is an observational study with an educational component, not a treatment trial. Results may not apply to non-twin populations, and the intervention's impact may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Sep 2033
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population comprises Polish twin individuals aged 15-44 years, who have provided informed consent, have a living co-twin, and present a positive family history (first- or second-degree relatives) of metabolic syndrome, its related comorbidities, or common complications.
- Ages
-
15 to 44 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria 1\. Age between 15 and 44 years. 2. Provision of informed consent to participate in the study. 3. Twin with a living co-twin. 4. Positive family history in first- and second-degree relatives of metabolic syndrome (MS), associated diseases, or the most common complications of the syndrome. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Exclusion Criteria Permanent exclusion criteria: 1. Co-twin does not consent to participate in the study. 2. Inability to obtain medical history of biological family members. 3. Presence of advanced liver fibrosis, cirrhosis, or liver cancer. 4. Known liver genetic disorders, autoimmune hepatitis, celiac disease, hemochromatosis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), cystic fibrosis, or Wilson's disease. 5. Current or chronic alcohol consumption \>20 g of ethanol/day in women and \>30 g/day in men. 6. Short bowel syndrome. 7. Cyanotic congenital heart defect. 8. Myasthenia. 9. Central nervous system degenerative diseases such as Alzheimer's disease, Parkinson's disease, or Huntington's disease. 10. Storage diseases involving the liver. 11. Active malignant neoplasm undergoing treatment (excluding non-melanoma skin cancers and melanoma treated non-pharmacologically). 12. Chronic kidney disease requiring renal replacement therapy. 13. Status post organ or tissue transplantation requiring immunosuppression. 14. Pituitary, hypothalamic, or adrenal hyperfunction/hypofunction requiring hormone supplementation. 15. Addiction to psychoactive substances or drugs. 16. Other severe and incurable diseases that, in the investigator's opinion, constitute a permanent contraindication for participation in the study. 17. Lack of cooperation by the volunteer during the visit to the Research Center. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Temporary exclusion criteria (after resolution, the volunteer may be enrolled): 1. Acute infection, low-grade fever or fever, or use of antibiotics at the time of recruitment or prior to the visit at the Research Center - inclusion possible after 6 weeks. 2. Any vaccination within the past 6 weeks. 3. Pregnancy and up to 6 months postpartum. 4. 3 months after the natural cessation of breastfeeding. 5. 3 months after surgery (does not apply to minor surgical procedures). 6. Untreated hyperthyroidism or hypothyroidism - inclusion possible 3 months after achieving euthyroidism. 7. Significant weight loss or gain in the past 3 months (\>10% of initial body weight) - inclusion possible 3 months after weight stabilization. 8. 6 months after discontinuation of temporary parenteral or enteral nutrition via feeding tube. 9. 12 months after bariatric surgery. 10. Systemic treatment with steroids, chemotherapy, immunosuppressive drugs, or biological therapy known to be hepatotoxic or potentially inducing abnormalities found in MS - inclusion possible at least 3 months after completing therapy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Uniwersytecki Szpital Kliniczny
RECRUITINGPoznan, Wielkopolska, 60-355, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly weight drug quiet gout attacks?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
- Can tailoring bypass length improve weight loss surgery results?
- Can AI predict your lifespan from a short video?
- Do obese children with autism face different heart risks?